[Form 3] Biofrontera Inc. Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

George Patrick Jones, listed at 120 Presidential Way, Suite 330, Woburn MA 01801, filed an initial Form 3 for Biofrontera Inc. (BFRI) reporting an event date of 08/25/2025. He is identified as a Director and Chief Commercial Officer. The filing states no securities are beneficially owned. The form was executed by an attorney-in-fact, Daniel Hakansson, on 09/16/2025.

Insights

Financial Analyst

TL;DR: Form 3 reports no beneficial ownership by an officer/director; neutral for valuation.

The filing notifies the market that a named executive officer and director, George Patrick Jones, has submitted an initial ownership report but discloses no beneficial holdings in Biofrontera (BFRI). This is a routine Section 16 disclosure indicating no direct or indirect equity position at the time of the event. There are no transactions, grants, or derivative positions recorded that would affect share count or immediate dilution.

Corporate Governance Expert

TL;DR: Governance filing is procedural; absence of holdings reduces potential related-party conflicts.

The Form 3 identifies Jones as both an officer and director and includes a power-of-attorney signature. The explicit statement that no securities are beneficially owned simplifies related-party oversight and reporting obligations. Nothing in the filing indicates late reporting or amendments beyond the initial submission; the disclosure appears complete and procedural.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Jones George Patrick

(Last) (First) (Middle)

120 PRESIDENTIAL WAY,

SUITE 330

(Street)

WOBURN, MA 01801

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/25/2025

3. Issuer Name and Ticker or Trading Symbol
Biofrontera Inc. [ BFRI ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Daniel Hakansson, Attorney-in-fact for George Jones	09/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 3 filed for BFRI disclose about George Patrick Jones's holdings?

The Form 3 states no securities are beneficially owned by George Patrick Jones in Biofrontera Inc. at the reported date.

What is George Patrick Jones's role at Biofrontera (BFRI)?

He is identified as a Director and the company's Chief Commercial Officer on the Form 3.

When is the event date that triggered the Form 3 filing for BFRI?

The date of the event requiring the statement is 08/25/2025 as shown on the filing.

Who signed the Form 3 on behalf of George Patrick Jones?

The filing was executed by Daniel Hakansson, Attorney-in-fact, and dated 09/16/2025.

Does the Form 3 report any derivative or option holdings for BFRI?

No. The filing contains no entries in the derivative securities section and states no securities are beneficially owned.